New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23-26 April), suggests that shorter telomeres, a feature of aging, may influence the ...
Apr 22, 2022
0
4
Around one in 10 Canadians has kidney disease and millions more are at risk. According to the Kidney Foundation of Canada, the number of people living with end-stage kidney disease or kidney failure has grown 35 percent since ...
Apr 13, 2022
0
4
Best known therapeutically as a treatment for bipolar disorder, lithium has long intrigued researchers with its potential age-defying properties.
Apr 11, 2022
0
18
Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who received a novel investigational device intended to repair the defective valve experienced significant improvements in blood ...
Apr 4, 2022
0
2
More than 40% of hospitalized individuals with COVID-19 have diabetes. But why is having diabetes a major risk factor for a more serious COVID-19 illness? Researchers now are starting to put the puzzle together.
Apr 4, 2022
0
4
A noninvasive ultrasound technique is capable of quickly pulverizing kidney stones, an early study shows—in what researchers call a first step toward a simpler, anesthesia-free treatment for the painful problem.
Mar 31, 2022
0
67
The total treatment costs for American Indian and Alaska Native older adults with dementia are US$2,943 higher than for those without dementia because of higher hospitalization costs, according to our new study published ...
Mar 31, 2022
0
2
Hitachi, Ltd., University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex ...
Mar 25, 2022
0
21
Antithrombotic therapy is prescribed to prevent thrombotic (blood clotting inside a blood vessel) events but the treatment also increases the likelihood of experiencing a bleeding event, which can be extremely serious if ...
Mar 25, 2022
0
13
For patients with moderate- to end-stage chronic kidney disease, elobixibat is associated with improvement in constipation and lipid metabolism, according to a study recently published in Frontiers in Medicine.
Mar 21, 2022
0
12
